GlassScriptPhysician profile
Terra Lomber
NPI 1457943888
$2,636.36
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $824 · 2022: $1,178 · 2023: $523 · 2024: $111.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $567 · Education: $67.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $567.14 |
| Education | $67.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $501.83 | 2021-2024 | |
| Jazz Pharmaceuticals INC. | $426.26 | 2021-2023 | |
| Ironshore Pharmaceuticals INC. | $397.84 | 2022-2024 | Jornay Pm |
| Neos Therapeutics, LP | $312.58 | 2021-2023 | Adzenys Xr-Odt |
| Tris Pharma INC | $198.99 | 2021-2022 | |
| Alkermes, INC. | $166.53 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $150.95 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $137.64 | 2022-2023 | Spravato |
| Takeda Pharmaceuticals U.S.A., INC. | $81.41 | 2021-2023 | Trintellix |
| Sunovion Pharmaceuticals INC. | $53.32 | 2021-2022 | |
| Adlon Therapeutics L.P. | $45.14 | 2021 | |
| Supernus Pharmaceuticals, INC. | $35.77 | 2022-2023 | Qelbree |
| Axsome Therapeutics, INC. | $34.80 | 2022-2023 | Auvelity |
| Corium, LLC | $29.57 | 2022-2023 | Azstarys |
| Harmony Biosciences LLC | $22.46 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tempus Ai, INC | $21.03 | 2024 | |
| Azurity Pharmaceuticals, INC. | $20.24 | 2023 | Horizant |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Terra Lomber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.